Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Update

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the target of a significant increase in short interest in the month of June. As of June 30th, there was short interest totaling 2,265 shares, an increase of 324.2% from the June 15th total of 534 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average daily volume of 7,256 shares, the short-interest ratio is presently 0.3 days.

Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF

A number of large investors have recently bought and sold shares of FMED. Jane Street Group LLC boosted its holdings in shares of Fidelity Disruptive Medicine ETF by 0.8% in the first quarter. Jane Street Group LLC now owns 66,382 shares of the company’s stock valued at $1,567,000 after acquiring an additional 499 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in Fidelity Disruptive Medicine ETF by 4.6% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 714,991 shares of the company’s stock worth $19,712,000 after purchasing an additional 31,629 shares in the last quarter. BXM Wealth LLC purchased a new position in Fidelity Disruptive Medicine ETF during the fourth quarter worth about $243,000. Glass Jacobson Investment Advisors llc lifted its position in Fidelity Disruptive Medicine ETF by 44.0% in the fourth quarter. Glass Jacobson Investment Advisors llc now owns 1,260 shares of the company’s stock valued at $34,000 after purchasing an additional 385 shares during the period. Finally, Vise Technologies Inc. purchased a new stake in Fidelity Disruptive Medicine ETF in the 4th quarter valued at approximately $234,000.

Fidelity Disruptive Medicine ETF Trading Down 1.8%

Shares of Fidelity Disruptive Medicine ETF stock traded down $0.54 during trading hours on Friday, hitting $29.56. 9,105 shares of the company were exchanged, compared to its average volume of 12,366. The business has a 50-day moving average of $26.04 and a 200-day moving average of $26.00. Fidelity Disruptive Medicine ETF has a 1 year low of $22.80 and a 1 year high of $30.33. The stock has a market capitalization of $47.30 million, a price-to-earnings ratio of 41.33 and a beta of 0.74.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.